32
total announcements
KIMS.NS · 15 min delayed
Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited held its 24th Annual General Meeting (AGM) on August 27, 2026, through video conferencing. The meeting was attended by 71 members, and the business mentioned in the Notice dated August 3, 2026, was transacted. The proceedings were recorded, and the e-voting system was provided by MUFG Intime India Private Limited.
Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited has clarified that a news report about acquiring a stake in Renova Hospitals for $52 million is false and baseless.
Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited has entered into an Operations and Management Agreement and Call Option Agreement with Aurevia Hospitals Private Limited for an initial term of 5 years to manage and operate Arete Hospitals in Hyderabad, Telangana.
Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited has informed the Exchange regarding allotment of 7702182 fully convertible warrants securities pursuant to Preferential Issue. The company has received Rs. 1,499,999,944.50 from the allottees for the warrant subscription, which is equivalent to 25% of the issue price of the said Warrants. The warrants shall be convertible into equity shares of the Company within a period of 18 months from the date of allotment of the Warrants.
Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited has announced its Q1 FY '27 earnings, with revenue of INR 1,196 crore, a growth of 36.1% year-on-year and 10.3% on quarter-on-quarter basis. EBITDA was INR 240 crore, with a growth of 20.1% year-on-year and 10.9% on quarter-on-quarter basis. PAT was INR 37 crores, with a growth of 11.8% year-on-year and a decline of 9.1% on quarter-on-quarter basis.
Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited has received in-principle approval from BSE and NSE for the issue and allotment of 77,02,182 warrants convertible into equity shares to promoters/promoter group on a preferential basis.
Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited has dispatched a letter to members whose email addresses are not registered with the company, providing a web-link to the Annual Report for the Financial Year 2025-26 and informing them about the 24th Annual General Meeting scheduled on August 27, 2026.
Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited has submitted its Business Responsibility and Sustainability Report (BRSR) for FY 2025-26, along with a Reasonable Assurance Report, as required by SEBI's listing regulations.
Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited has submitted its Integrated Annual Report for the FY 2025-26, as per Regulation 34(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 27, 2026
Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited has informed the Exchange about the availability of the audio recording of the Company's Conference Call dated August 7, 2025 with Investors/ Analysts for Q1 FY27 on the Company's website.
Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited has informed the Exchange about the schedule of an Analyst/Institutional Investor Meeting on August 12, 2026, at Emkay Confluence 2026 Mumbai, India.
Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited has informed the Exchange about the compliance with Regulation 47 of the SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015, regarding the unaudited (Standalone and Consolidated) financial results for the 01st quarter ended 30th June 2026.
Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited has issued a Monitoring Agency Report for the quarter ended June 30, 2026, as per SEBI Regulations and Monitoring Agency Agreement dated June 16, 2026. The report pertains to the utilization of the issue proceeds in relation to the objects of the issue based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable.
Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32, confirming NIL deviation or variation in the utilisation of proceeds of funds raised through Qualified Institutional Placement from the objects stated in the Placement Document dated 19th June, 2026.
Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited has announced its unaudited financial results for the first quarter ended June 30, 2026, showing a growth of 36.1% in total revenue and 20.1% in EBITDA. The company's consolidated EPS for the period ended June 30, 2026, was INR 1.04, a degrowth of 47.2% on a year-on-year basis. The company has also highlighted its clinical achievements, including a rare milestone of completing 10,000 brain tumour surgeries successfully and a successful treatment of a patient with Weber-Christian disease without liver transplant.
Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited has informed the Exchange about Investor Presentation, enclosing unaudited financial results for the 1st quarter ended June 30, 2026.
Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited has submitted its unaudited standalone financial results for the quarter ended June 30, 2026. The Board of Directors has approved the financial results, which include a loan of up to ₹650 Crores to be advanced to any subsidiaries or associates, and a loan of up to ₹25 Crore to KIMS Hospital Enterprises Private Limited. The financial results are available on the company's website and on the websites of BSE Ltd and National Stock Exchange of India Ltd.
Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited has informed the Exchange about a conference call with analysts and investors to discuss the company’s business strategy and outlook post the declaration of Q1FY27 financial results.